Advertisement
Home 2016 November

Monthly Archives: November 2016

Despite three decades of advancements in treating children with cancer

Long-Term Health Not Improved for Childhood Cancer Survivors

0
Those treated in 1990s more likely to report pain and poor health as adults, researchers say
The age at which cancer survivors are diagnosed with their disease may help predict their risk of death from cardiac disease

Age at Cancer Diagnosis Key in Determining Later Cardiac Risk

0
The younger the age at diagnosis, the greater the risk, study suggests
There is no indication of postprocedural cognitive impairment for patients undergoing coronary angiography or percutaneous coronary intervention

Coronary Angiography, PCI Don’t Impact Cognitive Function

0
No significant link between results of Montreal Cognitive Assessment test, cerebral microemboli
There is a probable interaction between paritaprevir/ritonavir/ombitasvir+dasabuvir plus ribavirin with warfarin

Probable Interaction ID’d for PrOD, Ribavirin With Warfarin

0
Case report shows probable interaction for ribavirin with paritaprevir/ritonavir/ombitasvir+dasabuvir
High transepidermal water loss in infancy is associated with atopic eczema at age 2 years

High Transepidermal Water Loss in Infancy Linked to Eczema

0
High TEWL in infancy linked to atopic eczema at age 2; correlation also seen for infants aged <3 months
Supported by the American Medical Association

AMA Highlights Role of Patient Shame in Opioid Disorders

0
Webinar on patient shame forms part of Providers' Clinical Support System for Opioid Therapies
BACH2 is a major risk locus for Addison's disease

BACH2 Identified As Risk Locus for Addison’s Disease

0
Extended exome capture array shows BACH2 correlates with Addison's disease development
An adapted clinical practice guideline

Guideline Adapted for Surgical Antimicrobial Prophylaxis

0
ADAPTE methodology was used to produce an adapted clinical practice guideline for SAP
Genetic variations correlate with mortality in the elderly

Genetic Mortality Risk Can Be Attenuated by Lifestyle

0
Mortality up to 64 percent lower for those with low-risk lifestyle profile, independent of genetic risk
Patients with type 1 diabetes diagnosed at age 15 to 27 years have low cumulative incidence of end-stage renal disease and increased mortality during long-term follow-up

Cumulative Incidence of ESRD Low in Patients With Type 1 DM

0
Cumulative incidence of ESRD 4.6 percent during 30 years' follow-up for those diagnosed at age 15 to 27